These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

605 related items for PubMed ID: 25654244

  • 1. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
    van der Meer FJ, Velthorst E, Genetic Risk and Outcome of Psychosis (GROUP) Investigators.
    Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial.
    Clausen L, Hjorthøj CR, Thorup A, Jeppesen P, Petersen L, Bertelsen M, Nordentoft M.
    Psychol Med; 2014 Jan; 44(1):117-26. PubMed ID: 23590927
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reasons for cannabis use in men with and without psychosis.
    Green B, Kavanagh DJ, Young RM.
    Drug Alcohol Rev; 2004 Dec; 23(4):445-53. PubMed ID: 15763749
    [Abstract] [Full Text] [Related]

  • 12. A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness.
    Madigan K, Brennan D, Lawlor E, Turner N, Kinsella A, O'Connor JJ, Russell V, Waddington JL, O'Callaghan E.
    Schizophr Res; 2013 Jan; 143(1):138-42. PubMed ID: 23187069
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Predictors of Relapse and Functioning in First-Episode Psychosis: A Two-Year Follow-Up Study.
    Bergé D, Mané A, Salgado P, Cortizo R, Garnier C, Gomez L, Diez-Aja C, Bulbena A, Pérez V.
    Psychiatr Serv; 2016 Feb; 67(2):227-33. PubMed ID: 26467909
    [Abstract] [Full Text] [Related]

  • 16. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH.
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [Abstract] [Full Text] [Related]

  • 17. No additive effect of cannabis on cognition in schizophrenia.
    Power BD, Dragovic M, Badcock JC, Morgan VA, Castle D, Jablensky A, Stefanis NC.
    Schizophr Res; 2015 Oct; 168(1-2):245-51. PubMed ID: 26235754
    [Abstract] [Full Text] [Related]

  • 18. Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study.
    van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M.
    Drug Alcohol Depend; 2013 Dec 01; 133(2):352-9. PubMed ID: 23886472
    [Abstract] [Full Text] [Related]

  • 19. Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up.
    Setién-Suero E, Martínez-García O, de la Foz VO, Vázquez-Bourgon J, Correa-Ghisays P, Ferro A, Crespo-Facorro B, Ayesa-Arriola R.
    Schizophr Res; 2018 Nov 01; 201():159-166. PubMed ID: 29861266
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.